BORNEM PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
BORNEM PHARMA
Largest movements
- Cash +€100,834
up €100,834 (+30.2%), from €334,018 to €434,852
mainly Net result for the year (+€247,989) and Other debts (+€59,773)
- Stocks and contracts +€31,365
up €31,365 (+12.9%), from €242,617 to €273,982
- Receivables within one year -€27,435
down €27,435 (-17.1%), from €160,706 to €133,271
of which Other amounts receivable: -€38,259
- Other debts +€59,773
up €59,773 (+14.4%), from €415,632 to €475,405
- Profit (loss) carried forward +€47,989
up €47,989 (+22.0%), from €217,955 to €265,944
- Debts after one year -€25,330
down €25,330 (-7.3%), from €349,357 to €324,028
- Tax, wage and social debts +€23,023
up €23,023 (+169.2%), from €13,607 to €36,630
of which Remuneration and social security: +€20,879
- Trade debts -€15,699
down €15,699 (-13.0%), from €120,969 to €105,270
- Gross operating margin +€75,135
up €75,135 (+19.8%), from €379,126 to €454,261
- Staff costs +€64,458
up €64,458 (+64.1%), from €100,574 to €165,032
- Taxes +€6,895
up €6,895 (+61.9%), from €11,134 to €18,029
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,180,052 | €1,270,120 | +€90,068 | +7.6% |
| Fixed assets | 21/28 | €423,862 | €412,442 | -€11,420 | -2.7% |
| Tangible fixed assets | 22/27 | €423,862 | €412,442 | -€11,420 | -2.7% |
| Land and buildings | 22 | €398,600 | €388,367 | -€10,233 | -2.6% |
| Plant, machinery and equipment | 23 | €25,238 | €22,139 | -€3,099 | -12.3% |
| Furniture and vehicles | 24 | €24 | €1,936 | +€1,912 | +8034.3% |
| Current assets | 29/58 | €756,190 | €857,678 | +€101,488 | +13.4% |
| Stocks and contracts in progress | 3 | €242,617 | €273,982 | +€31,365 | +12.9% |
| Stocks | 30/36 | €242,617 | €273,982 | +€31,365 | +12.9% |
| Amounts receivable within one year | 40/41 | €160,706 | €133,271 | -€27,435 | -17.1% |
| Trade receivables | 40 | €120,944 | €131,767 | +€10,824 | +8.9% |
| Other amounts receivable | 41 | €39,762 | €1,504 | -€38,259 | -96.2% |
| Cash at bank and in hand | 54/58 | €334,018 | €434,852 | +€100,834 | +30.2% |
| Deferred charges and accrued income | 490/1 | €18,849 | €15,573 | -€3,276 | -17.4% |
| Total equity and liabilities | 10/49 | €1,180,052 | €1,270,120 | +€90,068 | +7.6% |
| Equity | 10/15 | €255,321 | €303,310 | +€47,989 | +18.8% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €18,766 | €18,766 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Tax-exempt reserves | 132 | €16,906 | €16,906 | = | 0.0% |
| Profit (loss) carried forward | 14 | €217,955 | €265,944 | +€47,989 | +22.0% |
| Amounts payable | 17/49 | €924,732 | €966,810 | +€42,079 | +4.6% |
| Amounts payable after more than one year | 17 | €349,357 | €324,028 | -€25,330 | -7.3% |
| Financial debts | 170/4 | €349,357 | €324,028 | -€25,330 | -7.3% |
| Amounts payable within one year | 42/48 | €575,199 | €642,634 | +€67,436 | +11.7% |
| Current portion of amounts payable after more than one year | 42 | €24,991 | €25,330 | +€339 | +1.4% |
| Trade debts | 44 | €120,969 | €105,270 | -€15,699 | -13.0% |
| Suppliers | 440/4 | €120,969 | €105,270 | -€15,699 | -13.0% |
| Taxes, remuneration and social security | 45 | €13,607 | €36,630 | +€23,023 | +169.2% |
| Taxes | 450/3 | €113 | €2,257 | +€2,144 | +1899.5% |
| Remuneration and social security | 454/9 | €13,494 | €34,373 | +€20,879 | +154.7% |
| Other amounts payable | 47/48 | €415,632 | €475,405 | +€59,773 | +14.4% |
| Accrued charges and deferred income | 492/3 | €176 | €148 | -€28 | -15.7% |
| Remuneration, social security and pensions | 62 | €100,574 | €165,032 | +€64,458 | +64.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €15,061 | €15,246 | +€185 | +1.2% |
| Other operating charges | 640/8 | €495 | €587 | +€92 | +18.5% |
| Gross operating margin | 9900 | €379,126 | €454,261 | +€75,135 | +19.8% |
| Operating profit (loss) | 9901 | €262,995 | €273,395 | +€10,400 | +4.0% |
| Financial income | 75/76B | €470 | €1,560 | +€1,090 | +231.9% |
| Recurring financial income | 75 | €470 | €1,560 | +€1,090 | +231.9% |
| Financial charges | 65/66B | €9,218 | €8,938 | -€281 | -3.0% |
| Recurring financial charges | 65 | €9,218 | €8,938 | -€281 | -3.0% |
| Profit (loss) for the period before taxes | 9903 | €254,247 | €266,018 | +€11,771 | +4.6% |
| Income taxes | 67/77 | €11,134 | €18,029 | +€6,895 | +61.9% |
| Profit (loss) for the period | 9904 | €243,113 | €247,989 | +€4,876 | +2.0% |
| Profit (loss) for the period to be appropriated | 9905 | €243,113 | €247,989 | +€4,876 | +2.0% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 2 October 2026 via checked.be.